APLLTD - Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited Share Market Related News
-: Stock News :- APLLTD 10-06-2022 To 10-06-2022
-: Stock News :- APLLTD 10-06-2022 To 10-06-2022

✔️ Alembic Pharma gets USFDA nod for cancer treatment drug in US market
✔️ Alembic Pharma gets tentative USFDA approval for its Dasatinib tablets

View Full Story
-: Stock News :- APLLTD 24-05-2022 To 24-05-2022
-: Stock News :- APLLTD 24-05-2022 To 24-05-2022

✔️ Alembic Pharma gets USFDA approval to market Pirfenidone tablets
✔️ Alembic Pharma gets USFDA approval to market Pirfenidone tablets

View Full Story
-: Stock News :- APLLTD 11-05-2022 To 24-05-2022
-: Stock News :- APLLTD 11-05-2022 To 24-05-2022

✔️ Alembic Pharma gets final USFDA nod for generic version of Arformoterol Tartrate inhalation solution
✔️ Alembic Pharma gets USFDA approval to market Pirfenidone tablets

View Full Story
-: Stock News :- APLLTD 05-05-2022 To 05-05-2022
-: Stock News :- APLLTD 05-05-2022 To 05-05-2022

✔️ Hold Alembic Pharmaceuticals; target of Rs 758: KR Choksey
✔️ Hold Alembic Pharma; target of Rs 720: ICICI Direct

View Full Story
-: Stock News :- APLLTD 04-05-2022 To 05-05-2022
-: Stock News :- APLLTD 04-05-2022 To 05-05-2022

✔️ Alembic Pharma arm receives final USFDA approval for generic fever blisters drug
✔️ Hold Alembic Pharma; target of Rs 720: ICICI Direct

View Full Story
-: Stock News :- APLLTD 02-05-2022 To 02-05-2022
-: Stock News :- APLLTD 02-05-2022 To 02-05-2022

✔️ Alembic Pharma posts Q4 net of Rs 35 cr as India and US businesses grow
✔️ Alembic Pharma reports consolidated PAT at Rs 35 cr in March qtr
✔️ Alembic Pharma Q4 consolidated PAT at Rs 35 crore

View Full Story
-: Stock News :- APLLTD 12-04-2022 To 02-05-2022
-: Stock News :- APLLTD 12-04-2022 To 02-05-2022

✔️ Alembic Pharma arm gets final USFDA nod for generic version of Lidocaine and Prilocaine cream
✔️ Alembic Pharma reports consolidated PAT at Rs 35 cr in March qtr
✔️ Alembic Pharma Q4 consolidated PAT at Rs 35 crore

View Full Story
-: Stock News :- APLLTD 07-04-2022 To 02-05-2022
-: Stock News :- APLLTD 07-04-2022 To 02-05-2022

✔️ Alembic Pharma gets tentative USFDA nod for generic version of Dabigatran Etexilate capsules
✔️ Alembic Pharma reports consolidated PAT at Rs 35 cr in March qtr
✔️ Alembic Pharma Q4 consolidated PAT at Rs 35 crore

View Full Story
-: Stock News :- APLLTD 29-03-2022 To 29-03-2022
-: Stock News :- APLLTD 29-03-2022 To 29-03-2022

✔️ Alembic Pharma fully acquires Aleor Dermaceuticals from JV partner
✔️ Alembic Pharmaceuticals completes acquisition of Aleor Dermaceuticals
✔️ Alembic Pharmaceuticals acquires 100% stake in Aleor Dermaceuticals
✔️ Alembic Pharmaceuticals takes complete control of Aleor Dermaceuticals
✔️ Alembic Pharma acquires 100% stake in Aleor Dermaceuticals

View Full Story
-: Stock News :- APLLTD 08-03-2022 To 29-03-2022
-: Stock News :- APLLTD 08-03-2022 To 29-03-2022

✔️ Alembic Pharmaceuticals joint venture gets USFDA nod for anti-fungal drug
✔️ Alembic Pharmaceuticals' JV gets USFDA final nod for anti-fungal drug
✔️ Alembic Pharmaceuticals acquires 100% stake in Aleor Dermaceuticals
✔️ Alembic Pharmaceuticals takes complete control of Aleor Dermaceuticals
✔️ Alembic Pharma acquires 100% stake in Aleor Dermaceuticals

View Full Story
-: Stock News :- APLLTD 10-02-2022 To 29-03-2022
-: Stock News :- APLLTD 10-02-2022 To 29-03-2022

✔️ Price erosion in US drags Alembic Pharma's Q3 net down 40% to Rs 176 cr
✔️ Alembic Pharmaceuticals' JV gets USFDA final nod for anti-fungal drug
✔️ Alembic Pharmaceuticals acquires 100% stake in Aleor Dermaceuticals
✔️ Alembic Pharmaceuticals takes complete control of Aleor Dermaceuticals
✔️ Alembic Pharma acquires 100% stake in Aleor Dermaceuticals

View Full Story
-: Stock News :- APLLTD 02-02-2022 To 29-03-2022
-: Stock News :- APLLTD 02-02-2022 To 29-03-2022

✔️ Alembic Pharma gets tentative USFDA nod for fesoterodine fumarate extended-release tablets
✔️ Alembic Pharmaceuticals' JV gets USFDA final nod for anti-fungal drug
✔️ Alembic Pharmaceuticals acquires 100% stake in Aleor Dermaceuticals
✔️ Alembic Pharmaceuticals takes complete control of Aleor Dermaceuticals
✔️ Alembic Pharma acquires 100% stake in Aleor Dermaceuticals

View Full Story
-: Stock News :- APLLTD 10-01-2022 To 29-03-2022
-: Stock News :- APLLTD 10-01-2022 To 29-03-2022

✔️ Alembic Pharmaceuticals gets USFDA nod to market generic product
✔️ Alembic Pharmaceuticals' JV gets USFDA final nod for anti-fungal drug
✔️ Alembic Pharmaceuticals acquires 100% stake in Aleor Dermaceuticals
✔️ Alembic Pharmaceuticals takes complete control of Aleor Dermaceuticals
✔️ Alembic Pharma acquires 100% stake in Aleor Dermaceuticals

View Full Story
-: Stock News :- APLLTD 07-01-2022 To 29-03-2022
-: Stock News :- APLLTD 07-01-2022 To 29-03-2022

✔️ Alembic Pharma gets tentative USFDA approval for depressive disorder drug
✔️ Alembic Pharmaceuticals' JV gets USFDA final nod for anti-fungal drug
✔️ Alembic Pharmaceuticals acquires 100% stake in Aleor Dermaceuticals
✔️ Alembic Pharmaceuticals takes complete control of Aleor Dermaceuticals
✔️ Alembic Pharma acquires 100% stake in Aleor Dermaceuticals

View Full Story
-: Stock News :- APLLTD 06-01-2022 To 29-03-2022
-: Stock News :- APLLTD 06-01-2022 To 29-03-2022

✔️ Alembic Pharma gets USFDA nod for generic drug to treat Parkinson's disease
✔️ Alembic Pharma gets final nod from USFDA for generic drug to treat Parkinson's disease
✔️ Alembic Pharmaceuticals acquires 100% stake in Aleor Dermaceuticals
✔️ Alembic Pharmaceuticals takes complete control of Aleor Dermaceuticals
✔️ Alembic Pharma acquires 100% stake in Aleor Dermaceuticals

View Full Story
-: Stock News :- APLLTD 04-01-2022 To 29-03-2022
-: Stock News :- APLLTD 04-01-2022 To 29-03-2022

✔️ Alembic Pharma share price rises nearly 3% on USFDA approval for doxycycline
✔️ Alembic Pharma gets final nod from USFDA for generic drug to treat Parkinson's disease
✔️ Alembic Pharmaceuticals acquires 100% stake in Aleor Dermaceuticals
✔️ Alembic Pharmaceuticals takes complete control of Aleor Dermaceuticals
✔️ Alembic Pharma acquires 100% stake in Aleor Dermaceuticals

View Full Story
-: Stock News :- APLLTD 23-11-2021 To 29-03-2022
-: Stock News :- APLLTD 23-11-2021 To 29-03-2022

✔️ Alembic Pharma gets USFDA nod for formoterol fumarate inhalation solution
✔️ Alembic Pharma gets final USFDA nod for generic formoterol fumarate inhalation solution
✔️ Alembic Pharma share price rises 2% on USFDA approvals
✔️ Alembic Pharmaceuticals takes complete control of Aleor Dermaceuticals
✔️ Alembic Pharma acquires 100% stake in Aleor Dermaceuticals

View Full Story
-: Stock News :- APLLTD 17-11-2021 To 29-03-2022
-: Stock News :- APLLTD 17-11-2021 To 29-03-2022

✔️ Buy Alembic Pharma; target of Rs 790: ICICI Direct
✔️ Alembic Pharma gets final USFDA nod for generic formoterol fumarate inhalation solution
✔️ Alembic Pharma share price rises 2% on USFDA approvals
✔️ Alembic Pharmaceuticals takes complete control of Aleor Dermaceuticals
✔️ Alembic Pharma acquires 100% stake in Aleor Dermaceuticals

View Full Story
-: Stock News :- APLLTD 15-11-2021 To 29-03-2022
-: Stock News :- APLLTD 15-11-2021 To 29-03-2022

✔️ Hold Alembic Pharmaceuticals; target of Rs 778: KR Choksey
✔️ Alembic Pharma gets final USFDA nod for generic formoterol fumarate inhalation solution
✔️ Alembic Pharma share price rises 2% on USFDA approvals
✔️ Alembic Pharmaceuticals takes complete control of Aleor Dermaceuticals
✔️ Alembic Pharma acquires 100% stake in Aleor Dermaceuticals

View Full Story
-: Stock News :- APLLTD 11-11-2021 To 10-11-2021
-: Stock News :- APLLTD 11-11-2021 To 10-11-2021

✔️ Neutral Alembic Pharma; target of Rs 860: Motilal Oswal
✔️ Alembic Pharma dips 5% on disappointing September quarter results
✔️ Alembic Pharma share price falls 4% on weak Q2, USFDA observations
✔️ US business impact drags Alembic Pharmaceuticals' Q2 net
✔️ Alembic Pharma's Q2 net halves to Rs 169 cr as US biz takes 40% dip

View Full Story
-: Stock News :- APLLTD 06-09-2021 To 10-11-2021
-: Stock News :- APLLTD 06-09-2021 To 10-11-2021

✔️ Aleor Pharmaceuticals gets USFDA nod for generic antibacterial gel
✔️ Alembic Pharma dips 5% on disappointing September quarter results
✔️ Alembic Pharma share price falls 4% on weak Q2, USFDA observations
✔️ US business impact drags Alembic Pharmaceuticals' Q2 net
✔️ Alembic Pharma's Q2 net halves to Rs 169 cr as US biz takes 40% dip

View Full Story
-: Stock News :- APLLTD 05-08-2021 To 10-11-2021
-: Stock News :- APLLTD 05-08-2021 To 10-11-2021

✔️ Alembic Pharma gets final approval from USFDA for OCD treatment drug
✔️ Alembic Pharma gets final approval from USFDA for OCD treatment drug
✔️ Alembic Pharma share price falls 4% on weak Q2, USFDA observations
✔️ US business impact drags Alembic Pharmaceuticals' Q2 net
✔️ Alembic Pharma's Q2 net halves to Rs 169 cr as US biz takes 40% dip

View Full Story
-: Stock News :- APLLTD 29-07-2021 To 10-11-2021
-: Stock News :- APLLTD 29-07-2021 To 10-11-2021

✔️ Hold Alembic Pharma: target of Rs 885: ICICI Direct
✔️ Alembic Pharma gets final approval from USFDA for OCD treatment drug
✔️ Alembic Pharma share price falls 4% on weak Q2, USFDA observations
✔️ US business impact drags Alembic Pharmaceuticals' Q2 net
✔️ Alembic Pharma's Q2 net halves to Rs 169 cr as US biz takes 40% dip

View Full Story
-: Stock News :- APLLTD 28-07-2021 To 10-11-2021
-: Stock News :- APLLTD 28-07-2021 To 10-11-2021

✔️ Alembic Pharma stock slumps as US growth a concern
✔️ Alembic Pharma gets final approval from USFDA for OCD treatment drug
✔️ Alembic Pharma share price falls 4% on weak Q2, USFDA observations
✔️ US business impact drags Alembic Pharmaceuticals' Q2 net
✔️ Alembic Pharma's Q2 net halves to Rs 169 cr as US biz takes 40% dip

View Full Story
-: Stock News :- APLLTD 27-07-2021 To 26-07-2021
-: Stock News :- APLLTD 27-07-2021 To 26-07-2021

✔️ Alembic Pharma dips 8% on disappointing June quarter results
✔️ Alembic Pharma Standalone June 2021 Net Sales at Rs 1,269.69 crore, up 0.89% Y-o-Y
✔️ Alembic Pharma posts 45% dip in Q1 net at Rs 165 cr amid price erosion
✔️ Alembic Pharma Q1 net profit declines 45% to Rs 165 crore
✔️ Alembic Pharmaceuticals net profit drops 45% in Q1FY22 due to pricing pressure in US market

View Full Story
-: Stock News :- APLLTD 13-07-2021 To 26-07-2021
-: Stock News :- APLLTD 13-07-2021 To 26-07-2021

✔️ Alembic Pharmaceuticals Q1 PAT may dip 28.7% YoY to Rs 215 cr: KRChoksey
✔️ Alembic Pharma Standalone June 2021 Net Sales at Rs 1,269.69 crore, up 0.89% Y-o-Y
✔️ Alembic Pharma posts 45% dip in Q1 net at Rs 165 cr amid price erosion
✔️ Alembic Pharma Q1 net profit declines 45% to Rs 165 crore
✔️ Alembic Pharmaceuticals net profit drops 45% in Q1FY22 due to pricing pressure in US market

View Full Story
-: Stock News :- APLLTD 09-07-2021 To 26-07-2021
-: Stock News :- APLLTD 09-07-2021 To 26-07-2021

✔️ Alembic Pharma gets USFDA nod for cancer treatment drug
✔️ Alembic Pharma Standalone June 2021 Net Sales at Rs 1,269.69 crore, up 0.89% Y-o-Y
✔️ Alembic Pharma posts 45% dip in Q1 net at Rs 165 cr amid price erosion
✔️ Alembic Pharma Q1 net profit declines 45% to Rs 165 crore
✔️ Alembic Pharmaceuticals net profit drops 45% in Q1FY22 due to pricing pressure in US market

View Full Story
-: Stock News :- APLLTD 08-07-2021 To 26-07-2021
-: Stock News :- APLLTD 08-07-2021 To 26-07-2021

✔️ Alembic Pharma gets USFDA approval for anti-depressant drug
✔️ Alembic Pharma Standalone June 2021 Net Sales at Rs 1,269.69 crore, up 0.89% Y-o-Y
✔️ Alembic Pharma posts 45% dip in Q1 net at Rs 165 cr amid price erosion
✔️ Alembic Pharma Q1 net profit declines 45% to Rs 165 crore
✔️ Alembic Pharmaceuticals net profit drops 45% in Q1FY22 due to pricing pressure in US market

View Full Story
-: Stock News :- APLLTD 01-07-2021 To 26-07-2021
-: Stock News :- APLLTD 01-07-2021 To 26-07-2021

✔️ Alembic Pharma gets USFDA nod for generic Nitrofurantoin capsules
✔️ Alembic Pharma Standalone June 2021 Net Sales at Rs 1,269.69 crore, up 0.89% Y-o-Y
✔️ Alembic Pharma posts 45% dip in Q1 net at Rs 165 cr amid price erosion
✔️ Alembic Pharma Q1 net profit declines 45% to Rs 165 crore
✔️ Alembic Pharmaceuticals net profit drops 45% in Q1FY22 due to pricing pressure in US market

View Full Story
-: Stock News :- APLLTD 16-06-2021 To 26-07-2021
-: Stock News :- APLLTD 16-06-2021 To 26-07-2021

✔️ Alembic Pharma JV Aleor Dermaceuticals gets USFDA nod for testosterone topical solution
✔️ Alembic Pharma Standalone June 2021 Net Sales at Rs 1,269.69 crore, up 0.89% Y-o-Y
✔️ Alembic Pharma posts 45% dip in Q1 net at Rs 165 cr amid price erosion
✔️ Alembic Pharma Q1 net profit declines 45% to Rs 165 crore
✔️ Alembic Pharmaceuticals net profit drops 45% in Q1FY22 due to pricing pressure in US market

View Full Story
-: Stock News :- APLLTD 26-05-2021 To 26-07-2021
-: Stock News :- APLLTD 26-05-2021 To 26-07-2021

✔️ Zydus & TLC sign pact to market drug 'Liposomal Amphotericin B' to treat black fungus in India
✔️ Alembic Pharma Standalone June 2021 Net Sales at Rs 1,269.69 crore, up 0.89% Y-o-Y
✔️ Alembic Pharma posts 45% dip in Q1 net at Rs 165 cr amid price erosion
✔️ Alembic Pharma Q1 net profit declines 45% to Rs 165 crore
✔️ Alembic Pharmaceuticals net profit drops 45% in Q1FY22 due to pricing pressure in US market

View Full Story
-: Stock News :- APLLTD 25-05-2021 To 26-07-2021
-: Stock News :- APLLTD 25-05-2021 To 26-07-2021

✔️ Hold Alembic Pharma: target of Rs 1055: ICICI Direct
✔️ Alembic Pharma Standalone June 2021 Net Sales at Rs 1,269.69 crore, up 0.89% Y-o-Y
✔️ Alembic Pharma posts 45% dip in Q1 net at Rs 165 cr amid price erosion
✔️ Alembic Pharma Q1 net profit declines 45% to Rs 165 crore
✔️ Alembic Pharmaceuticals net profit drops 45% in Q1FY22 due to pricing pressure in US market

View Full Story
-: Stock News :- APLLTD 14-05-2021 To 26-07-2021
-: Stock News :- APLLTD 14-05-2021 To 26-07-2021

✔️ Alembic Pharmaceuticals gets USFDA nod for bipolar depression drug
✔️ Alembic Pharma Standalone June 2021 Net Sales at Rs 1,269.69 crore, up 0.89% Y-o-Y
✔️ Alembic Pharma posts 45% dip in Q1 net at Rs 165 cr amid price erosion
✔️ Alembic Pharma Q1 net profit declines 45% to Rs 165 crore
✔️ Alembic Pharmaceuticals net profit drops 45% in Q1FY22 due to pricing pressure in US market

View Full Story
-: Stock News :- APLLTD 06-05-2021 To 26-07-2021
-: Stock News :- APLLTD 06-05-2021 To 26-07-2021

✔️ Alembic Pharma Consolidated March 2021 Net Sales at Rs 1,280.39 crore, up 6.1% Y-o-Y
✔️ Alembic Pharma Standalone June 2021 Net Sales at Rs 1,269.69 crore, up 0.89% Y-o-Y
✔️ Alembic Pharma posts 45% dip in Q1 net at Rs 165 cr amid price erosion
✔️ Alembic Pharma Q1 net profit declines 45% to Rs 165 crore
✔️ Alembic Pharmaceuticals net profit drops 45% in Q1FY22 due to pricing pressure in US market

View Full Story
-: Stock News :- APLLTD 05-05-2021 To 26-07-2021
-: Stock News :- APLLTD 05-05-2021 To 26-07-2021

✔️ Alembic Pharma falls 6% post March quarter results
✔️ API supply concerns from China fuel Alembic Pharma's global prospects
✔️ Alembic Pharma Q4 net up 12% to Rs 251 cr on strong API, global businesses
✔️ Alembic Pharma Q1 net profit declines 45% to Rs 165 crore
✔️ Alembic Pharmaceuticals net profit drops 45% in Q1FY22 due to pricing pressure in US market

View Full Story
-: Stock News :- APLLTD 08-04-2021 To 26-07-2021
-: Stock News :- APLLTD 08-04-2021 To 26-07-2021

✔️ Alembic Pharma share price jumps 3% on tentative USFDA approval
✔️ API supply concerns from China fuel Alembic Pharma's global prospects
✔️ Alembic Pharma Q4 net up 12% to Rs 251 cr on strong API, global businesses
✔️ Alembic Pharma Q1 net profit declines 45% to Rs 165 crore
✔️ Alembic Pharmaceuticals net profit drops 45% in Q1FY22 due to pricing pressure in US market

View Full Story
-: Stock News :- APLLTD 06-04-2021 To 26-07-2021
-: Stock News :- APLLTD 06-04-2021 To 26-07-2021

✔️ Alembic Pharma's injectables plant launch may face some delay
✔️ API supply concerns from China fuel Alembic Pharma's global prospects
✔️ Alembic Pharma Q4 net up 12% to Rs 251 cr on strong API, global businesses
✔️ Alembic Pharma Q1 net profit declines 45% to Rs 165 crore
✔️ Alembic Pharmaceuticals net profit drops 45% in Q1FY22 due to pricing pressure in US market

View Full Story
-: Stock News :- APLLTD 09-02-2021 To 26-07-2021
-: Stock News :- APLLTD 09-02-2021 To 26-07-2021

✔️ Novel blood cancer drug developed by Alembic Pharma's associate Rhizen gets US approval
✔️ API supply concerns from China fuel Alembic Pharma's global prospects
✔️ Alembic Pharma Q4 net up 12% to Rs 251 cr on strong API, global businesses
✔️ Alembic Pharma Q1 net profit declines 45% to Rs 165 crore
✔️ Alembic Pharmaceuticals net profit drops 45% in Q1FY22 due to pricing pressure in US market

View Full Story
-: Stock News :- APLLTD 08-02-2021 To 26-07-2021
-: Stock News :- APLLTD 08-02-2021 To 26-07-2021

✔️ Alembic Pharma gets five observations from USFDA for Gujarat facility
✔️ Alembic Pharma gets five observations from USFDA for Gujarat facility
✔️ Alembic Pharma Q4 net up 12% to Rs 251 cr on strong API, global businesses
✔️ Alembic Pharma Q1 net profit declines 45% to Rs 165 crore
✔️ Alembic Pharmaceuticals net profit drops 45% in Q1FY22 due to pricing pressure in US market

View Full Story
-: Stock News :- APLLTD 02-02-2021 To 26-07-2021
-: Stock News :- APLLTD 02-02-2021 To 26-07-2021

✔️ Neutral Alembic Pharma; target of Rs 1070: Motilal Oswal
✔️ Alembic Pharma gets five observations from USFDA for Gujarat facility
✔️ Alembic Pharma Q4 net up 12% to Rs 251 cr on strong API, global businesses
✔️ Alembic Pharma Q1 net profit declines 45% to Rs 165 crore
✔️ Alembic Pharmaceuticals net profit drops 45% in Q1FY22 due to pricing pressure in US market

View Full Story
-: Stock News :- APLLTD 28-01-2021 To 26-07-2021
-: Stock News :- APLLTD 28-01-2021 To 26-07-2021

✔️ Hold Alembic Pharma; target of Rs 1055: ICICI Direct
✔️ Alembic Pharma gets five observations from USFDA for Gujarat facility
✔️ Alembic Pharma Q4 net up 12% to Rs 251 cr on strong API, global businesses
✔️ Alembic Pharma Q1 net profit declines 45% to Rs 165 crore
✔️ Alembic Pharmaceuticals net profit drops 45% in Q1FY22 due to pricing pressure in US market

View Full Story
-: Stock News :- APLLTD 22-01-2021 To 21-01-2021
-: Stock News :- APLLTD 22-01-2021 To 21-01-2021

✔️ Alembic Pharma bags USFDA final nod for orthostatic hypotension tablets
✔️ Alembic Pharma share price gains on USFDA approval
✔️ Alembic Pharma gets USFDA nod for low blood pressure treatment drug
✔️ Alembic Pharma head Amin says confident of sustaining growth momentum
✔️ Alembic Pharma Standalone December 2020 Net Sales at Rs 1,235.77 crore, up 17.43% Y-o-Y

View Full Story
-: Stock News :- APLLTD 20-01-2021 To 19-01-2021
-: Stock News :- APLLTD 20-01-2021 To 19-01-2021

✔️ Alembic Pharma extends decline on mixed December quarter results
✔️ Alembic Pharma Q3 net up 25% as US formulations business moderates
✔️ Alembic Pharma Standalone December 2020 Net Sales at Rs 1,235.77 crore, up 17.43% Y-o-Y
✔️ Alembic Pharma Consolidated December 2020 Net Sales at Rs 1,314.33 crore, up 8.7% Y-o-Y
✔️ Alembic Pharma Q3 standalone net up 19% at 277 crore

View Full Story
-: Stock News :- APLLTD 03-12-2020 To 19-01-2021
-: Stock News :- APLLTD 03-12-2020 To 19-01-2021

✔️ Alembic Pharma gets USFDA nod for pills to treat salt, water retention
✔️ Alembic Pharma share price rises after US FDA nod to metolazone tablets
✔️ Alembic Pharma Standalone December 2020 Net Sales at Rs 1,235.77 crore, up 17.43% Y-o-Y
✔️ Alembic Pharma Consolidated December 2020 Net Sales at Rs 1,314.33 crore, up 8.7% Y-o-Y
✔️ Alembic Pharma Q3 standalone net up 19% at 277 crore

View Full Story
-: Stock News :- APLLTD 22-11-2020 To 19-01-2021
-: Stock News :- APLLTD 22-11-2020 To 19-01-2021

✔️ Why you should hold the stock of Alembic Pharma
✔️ Alembic Pharma share price rises after US FDA nod to metolazone tablets
✔️ Alembic Pharma Standalone December 2020 Net Sales at Rs 1,235.77 crore, up 17.43% Y-o-Y
✔️ Alembic Pharma Consolidated December 2020 Net Sales at Rs 1,314.33 crore, up 8.7% Y-o-Y
✔️ Alembic Pharma Q3 standalone net up 19% at 277 crore

View Full Story
-: Stock News :- APLLTD 09-11-2020 To 19-01-2021
-: Stock News :- APLLTD 09-11-2020 To 19-01-2021

✔️ Alembic Pharma gets tentative USFDA nod for breast cancer treatment drug
✔️ Alembic Pharma share price rises after US FDA nod to metolazone tablets
✔️ Alembic Pharma Standalone December 2020 Net Sales at Rs 1,235.77 crore, up 17.43% Y-o-Y
✔️ Alembic Pharma Consolidated December 2020 Net Sales at Rs 1,314.33 crore, up 8.7% Y-o-Y
✔️ Alembic Pharma Q3 standalone net up 19% at 277 crore

View Full Story
-: Stock News :- APLLTD 28-10-2020 To 19-01-2021
-: Stock News :- APLLTD 28-10-2020 To 19-01-2021

✔️ Buy Alembic Pharmaceuticals; target of Rs 1286 KR Choksey
✔️ Alembic Pharma share price rises after US FDA nod to metolazone tablets
✔️ Alembic Pharma Standalone December 2020 Net Sales at Rs 1,235.77 crore, up 17.43% Y-o-Y
✔️ Alembic Pharma Consolidated December 2020 Net Sales at Rs 1,314.33 crore, up 8.7% Y-o-Y
✔️ Alembic Pharma Q3 standalone net up 19% at 277 crore

View Full Story
-: Stock News :- APLLTD 26-10-2020 To 19-01-2021
-: Stock News :- APLLTD 26-10-2020 To 19-01-2021

✔️ Alembic Pharma gets USFDA nod for elevated intraocular pressure drug
✔️ Alembic Pharmaceuticals gets USFDA nod for elevated intraocular pressure drug
✔️ Alembic Pharma share price slips 2% despite FDA nod for glaucoma drug
✔️ Alembic Pharma Consolidated December 2020 Net Sales at Rs 1,314.33 crore, up 8.7% Y-o-Y
✔️ Alembic Pharma Q3 standalone net up 19% at 277 crore

View Full Story
-: Stock News :- APLLTD 23-10-2020 To 19-01-2021
-: Stock News :- APLLTD 23-10-2020 To 19-01-2021

✔️ Buy Alembic Pharma; target of Rs 1180: YES Securities
✔️ Alembic Pharmaceuticals gets USFDA nod for elevated intraocular pressure drug
✔️ Alembic Pharma share price slips 2% despite FDA nod for glaucoma drug
✔️ Alembic Pharma Consolidated December 2020 Net Sales at Rs 1,314.33 crore, up 8.7% Y-o-Y
✔️ Alembic Pharma Q3 standalone net up 19% at 277 crore

View Full Story
-: Stock News :- APLLTD 22-10-2020 To 19-01-2021
-: Stock News :- APLLTD 22-10-2020 To 19-01-2021

✔️ Alembic Pharma Q2 net profit up 35% at Rs 333 crore on robust sales
✔️ Alembic Pharma's Q2 net profit up 35% at Rs 333 cr on strong domestic biz
✔️ Alembic Pharma reports 35% rise in net profit to Rs 333 cr for Sept quarter
✔️ Alembic Pharma JV gets USFDA nod for antifungal topical solution
✔️ Alembic Pharma Q3 standalone net up 19% at 277 crore

View Full Story
-: Stock News :- APLLTD 21-10-2020 To 19-01-2021
-: Stock News :- APLLTD 21-10-2020 To 19-01-2021

✔️ Alembic Pharma gets USFDA nod for cholesterol lowering drug
✔️ Alembic Pharma gets USFDA nod for cholesterol lowering drug
✔️ Alembic Pharma reports 35% rise in net profit to Rs 333 cr for Sept quarter
✔️ Alembic Pharma JV gets USFDA nod for antifungal topical solution
✔️ Alembic Pharma Q3 standalone net up 19% at 277 crore

View Full Story
-: Stock News :- APLLTD 16-10-2020 To 19-01-2021
-: Stock News :- APLLTD 16-10-2020 To 19-01-2021

✔️ Alembic Pharmaceuticals gets USFDA nod for anti-viral drug
✔️ Alembic Pharma gets USFDA nod for anti-viral drug Amantadine Hydrochloride
✔️ Alembic Pharma reports 35% rise in net profit to Rs 333 cr for Sept quarter
✔️ Alembic Pharma JV gets USFDA nod for antifungal topical solution
✔️ Alembic Pharma Q3 standalone net up 19% at 277 crore

View Full Story
-: Stock News :- APLLTD 13-10-2020 To 19-01-2021
-: Stock News :- APLLTD 13-10-2020 To 19-01-2021

✔️ Alembic Pharma share rises 3% after associate firm inks deal to develop Tenalisib
✔️ Alembic Pharma arm inks pact with Curon to develop cancer treatment drug in Greater China
✔️ Alembic Pharma reports 35% rise in net profit to Rs 333 cr for Sept quarter
✔️ Alembic Pharma JV gets USFDA nod for antifungal topical solution
✔️ Alembic Pharma Q3 standalone net up 19% at 277 crore

View Full Story
-: Stock News :- APLLTD 07-09-2020 To 19-01-2021
-: Stock News :- APLLTD 07-09-2020 To 19-01-2021

✔️ Alembic Pharmaceuticals arm gets tentative USFDA nod for drug to treat pulmonary arterial hypertension
✔️ Alembic Pharma arm gets tentative USFDA nod for drug to treat hypertension
✔️ Alembic Pharma share price in the red; company gets tentative FDA nod for BP medicine
✔️ Alembic Pharma JV gets USFDA nod for antifungal topical solution
✔️ Alembic Pharma Q3 standalone net up 19% at 277 crore

View Full Story
-: Stock News :- APLLTD 02-09-2020 To 19-01-2021
-: Stock News :- APLLTD 02-09-2020 To 19-01-2021

✔️ Alembic Pharma (930.3): Sell
✔️ Alembic Pharma arm gets tentative USFDA nod for drug to treat hypertension
✔️ Alembic Pharma share price in the red; company gets tentative FDA nod for BP medicine
✔️ Alembic Pharma JV gets USFDA nod for antifungal topical solution
✔️ Alembic Pharma Q3 standalone net up 19% at 277 crore

View Full Story
-: Stock News :- APLLTD 27-08-2020 To 19-01-2021
-: Stock News :- APLLTD 27-08-2020 To 19-01-2021

✔️ Alembic Pharma share price gains 3% on USFDA nod for diabetes drugs
✔️ Alembic Pharma gets USFDA's tentative approval for type 2 diabetes drug
✔️ Alembic Pharma share price gains after tentative FDA nod for diabetes drug
✔️ Alembic Pharma JV gets USFDA nod for antifungal topical solution
✔️ Alembic Pharma Q3 standalone net up 19% at 277 crore

View Full Story
-: Stock News :- APLLTD 25-08-2020 To 19-01-2021
-: Stock News :- APLLTD 25-08-2020 To 19-01-2021

✔️ Alembic Pharmaceuticals's JV gets USFDA nod for skin disorder treatment drug
✔️ Alembic Pharma gets USFDA's tentative approval for type 2 diabetes drug
✔️ Alembic Pharma share price gains after tentative FDA nod for diabetes drug
✔️ Alembic Pharma JV gets USFDA nod for antifungal topical solution
✔️ Alembic Pharma Q3 standalone net up 19% at 277 crore

View Full Story
-: Stock News :- APLLTD 13-08-2020 To 19-01-2021
-: Stock News :- APLLTD 13-08-2020 To 19-01-2021

✔️ Alembic Pharma share gains 3% on USFDA approval for antifungal drug
✔️ Alembic Pharma share price gains 3% on USFDA approval for antifungal
✔️ Alembic Pharma share price gains after tentative FDA nod for diabetes drug
✔️ Alembic Pharma JV gets USFDA nod for antifungal topical solution
✔️ Alembic Pharma Q3 standalone net up 19% at 277 crore

View Full Story
-: Stock News :- APLLTD 05-08-2020 To 19-01-2021
-: Stock News :- APLLTD 05-08-2020 To 19-01-2021

✔️ Alembic Pharmaceuticals gets USFDA nod for erectile dysfunction drug
✔️ Alembic Pharma share price gains 3% on USFDA approval for antifungal
✔️ Alembic Pharma share price gains after tentative FDA nod for diabetes drug
✔️ Alembic Pharma JV gets USFDA nod for antifungal topical solution
✔️ Alembic Pharma Q3 standalone net up 19% at 277 crore

View Full Story
-: Stock News :- APLLTD 27-07-2020 To 19-01-2021
-: Stock News :- APLLTD 27-07-2020 To 19-01-2021

✔️ Alembic Pharma gets board approval to raise up to Rs 1,000 cr via QIP
✔️ Alembic Pharma gets nod to raise up to Rs 1,000 crore via QIP
✔️ Alembic Pharma gets board approval to raise up to Rs 1,000 crore via QIP
✔️ Alembic Pharma JV gets USFDA nod for antifungal topical solution
✔️ Alembic Pharma Q3 standalone net up 19% at 277 crore

View Full Story
-: Stock News :- APLLTD 23-07-2020 To 22-07-2020
-: Stock News :- APLLTD 23-07-2020 To 22-07-2020

✔️ Neutral Alembic Pharma; target of Rs 1122: Motilal Oswal
✔️ Alembic Pharma Standalone June 2020 Net Sales at Rs 1,258.43 crore, up 40.33% Y-o-Y
✔️ Alembic Pharmaceuticals' US biz holds the key to investor returns
✔️ Alembic Pharma Q1 PBT almost doubles to Rs 359 cr, income rises 40%
✔️ Alembic Pharma Q1 profit rises to 319 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 20-07-2020 To 22-07-2020
-: Stock News :- APLLTD 20-07-2020 To 22-07-2020

✔️ Alembic Pharma share price hits 52-week high on tentative US FDA approval for diabetes drug
✔️ Alembic Pharma gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharma gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharmaceuticals gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharma Q1 profit rises to 319 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 12-07-2020 To 22-07-2020
-: Stock News :- APLLTD 12-07-2020 To 22-07-2020

✔️ Alembic Pharma sees domestic business growing in double digits this fiscal
✔️ Alembic Pharma gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharma gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharmaceuticals gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharma Q1 profit rises to 319 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 07-07-2020 To 22-07-2020
-: Stock News :- APLLTD 07-07-2020 To 22-07-2020

✔️ Neutral Alembic Pharmaceuticals; target of Rs 975: Motilal Oswal
✔️ Alembic Pharma gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharma gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharmaceuticals gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharma Q1 profit rises to 319 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 01-07-2020 To 22-07-2020
-: Stock News :- APLLTD 01-07-2020 To 22-07-2020

✔️ Alembic Pharma gets USFDA nod for generic Doxycycline Hyclate tablets
✔️ Alembic Pharma gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharma gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharmaceuticals gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharma Q1 profit rises to 319 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 23-06-2020 To 22-07-2020
-: Stock News :- APLLTD 23-06-2020 To 22-07-2020

✔️ Buy Alembic Pharma; target of Rs 1100: YES Securities
✔️ Alembic Pharma gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharma gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharmaceuticals gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharma Q1 profit rises to 319 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 22-06-2020 To 22-07-2020
-: Stock News :- APLLTD 22-06-2020 To 22-07-2020

✔️ Alembic Pharma share hits all-time high on USFDA nod for Rivaroxaban tablets
✔️ Alembic Pharma gets tentative USFDA nod for generic Rivaroxaban tablets
✔️ Alembic Pharma gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharmaceuticals gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharma Q1 profit rises to 319 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 19-06-2020 To 22-07-2020
-: Stock News :- APLLTD 19-06-2020 To 22-07-2020

✔️ Alembic Pharma gets USFDA nod for generic Adapalene gel for acne treatment
✔️ Alembic Pharma gets tentative USFDA nod for generic Rivaroxaban tablets
✔️ Alembic Pharma gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharmaceuticals gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharma Q1 profit rises to 319 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 16-06-2020 To 22-07-2020
-: Stock News :- APLLTD 16-06-2020 To 22-07-2020

✔️ Alembic Pharma hits 52-week high on final USFDA approval for Deferasirox tablets
✔️ Alembic Pharma gains 6% on USFDA nod for its iron tablet
✔️ Alembic Pharma gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharmaceuticals gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharma Q1 profit rises to 319 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 22-05-2020 To 22-07-2020
-: Stock News :- APLLTD 22-05-2020 To 22-07-2020

✔️ Alembic Pharma Q4 profit jumps 81% to Rs 225 crore, FY20 net grows 42%
✔️ Alembic Pharma gains 6% on USFDA nod for its iron tablet
✔️ Alembic Pharma gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharmaceuticals gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharma Q1 profit rises to 319 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 20-05-2020 To 22-07-2020
-: Stock News :- APLLTD 20-05-2020 To 22-07-2020

✔️ Buy Alembic Pharma ; target of Rs 1100: YES Securities
✔️ Alembic Pharma gains 6% on USFDA nod for its iron tablet
✔️ Alembic Pharma gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharmaceuticals gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharma Q1 profit rises to 319 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 17-05-2020 To 22-07-2020
-: Stock News :- APLLTD 17-05-2020 To 22-07-2020

✔️ Trading pick of the week: Buy Alembic Pharmaceuticals
✔️ Alembic Pharma gains 6% on USFDA nod for its iron tablet
✔️ Alembic Pharma gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharmaceuticals gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharma Q1 profit rises to 319 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 09-05-2020 To 22-07-2020
-: Stock News :- APLLTD 09-05-2020 To 22-07-2020

✔️ How R&D; spends make Alembic Pharmaceuticals a good buy
✔️ Alembic Pharma gains 6% on USFDA nod for its iron tablet
✔️ Alembic Pharma gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharmaceuticals gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharma Q1 profit rises to 319 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 28-04-2020 To 22-07-2020
-: Stock News :- APLLTD 28-04-2020 To 22-07-2020

✔️ Alembic Pharma Consolidated March 2020 Net Sales at Rs 1,206.83 crore, up 30.19% Y-o-Y
✔️ Alembic Pharma gains 6% on USFDA nod for its iron tablet
✔️ Alembic Pharma gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharmaceuticals gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharma Q1 profit rises to 319 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 27-04-2020 To 22-07-2020
-: Stock News :- APLLTD 27-04-2020 To 22-07-2020

✔️ After strong FY20, Alembic Pharma's FY21 outlook, too, remains firm
✔️ Alembic Pharma gains 6% on USFDA nod for its iron tablet
✔️ Alembic Pharma gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharmaceuticals gets tentative nod from USFDA for diabetes management drug
✔️ Alembic Pharma Q1 profit rises to 319 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 24-04-2020 To 22-07-2020
-: Stock News :- APLLTD 24-04-2020 To 22-07-2020

✔️ Alembic Pharma shares jump 5% after robust Q4 profit; volumes surge 250%
✔️ Alembic Pharma hits 52-wk high, rallies 20% in 3 days on robust Q4 numbers
✔️ Alembic Pharma Q4 net up 81% to Rs 225 crore
✔️ Alembic Pharma posts highest-ever revenues, profit for FY2020
✔️ Alembic Pharma share prices surges 10% on highest-ever profit, revenue in FY20
✔️ Alembic Pharma surges 10% on strong Q4 results; stock zooms 56% in a month
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 20-04-2020 To 22-07-2020
-: Stock News :- APLLTD 20-04-2020 To 22-07-2020

✔️ Alembic Pharma share price up over 3% after USFDA tentatively approves conjunctivitis-related drug
✔️ Alembic Pharma hits 52-wk high, rallies 20% in 3 days on robust Q4 numbers
✔️ Alembic Pharma Q4 net up 81% to Rs 225 crore
✔️ Alembic Pharma posts highest-ever revenues, profit for FY2020
✔️ Alembic Pharma share prices surges 10% on highest-ever profit, revenue in FY20
✔️ Alembic Pharma surges 10% on strong Q4 results; stock zooms 56% in a month
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 27-03-2020 To 22-07-2020
-: Stock News :- APLLTD 27-03-2020 To 22-07-2020

✔️ Alembic says enough capacity to meet rising demand for azithromycin
✔️ Alembic Pharma hits 52-wk high, rallies 20% in 3 days on robust Q4 numbers
✔️ Alembic Pharma Q4 net up 81% to Rs 225 crore
✔️ Alembic Pharma posts highest-ever revenues, profit for FY2020
✔️ Alembic Pharma share prices surges 10% on highest-ever profit, revenue in FY20
✔️ Alembic Pharma surges 10% on strong Q4 results; stock zooms 56% in a month
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 20-03-2020 To 22-07-2020
-: Stock News :- APLLTD 20-03-2020 To 22-07-2020

✔️ On analyst call, Alembic Pharma says China supply chain returning to normal
✔️ Alembic Pharma hits 52-wk high, rallies 20% in 3 days on robust Q4 numbers
✔️ Alembic Pharma Q4 net up 81% to Rs 225 crore
✔️ Alembic Pharma posts highest-ever revenues, profit for FY2020
✔️ Alembic Pharma share prices surges 10% on highest-ever profit, revenue in FY20
✔️ Alembic Pharma surges 10% on strong Q4 results; stock zooms 56% in a month
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 17-03-2020 To 22-07-2020
-: Stock News :- APLLTD 17-03-2020 To 22-07-2020

✔️ Alembic Pharma gets EIR from USFDA for API facility at Karakhadi
✔️ Alembic Pharma gets EIR from USFDA, share price down over 1%
✔️ Alembic Pharma Q4 net up 81% to Rs 225 crore
✔️ Alembic Pharma posts highest-ever revenues, profit for FY2020
✔️ Alembic Pharma share prices surges 10% on highest-ever profit, revenue in FY20
✔️ Alembic Pharma surges 10% on strong Q4 results; stock zooms 56% in a month
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 16-03-2020 To 22-07-2020
-: Stock News :- APLLTD 16-03-2020 To 22-07-2020

✔️ Alembic Pharma share price sheds 4% as USFDA issues 4 observations
✔️ Alembic Pharma gets EIR from USFDA, share price down over 1%
✔️ Alembic Pharma Q4 net up 81% to Rs 225 crore
✔️ Alembic Pharma posts highest-ever revenues, profit for FY2020
✔️ Alembic Pharma share prices surges 10% on highest-ever profit, revenue in FY20
✔️ Alembic Pharma surges 10% on strong Q4 results; stock zooms 56% in a month
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 28-01-2020 To 22-07-2020
-: Stock News :- APLLTD 28-01-2020 To 22-07-2020

✔️ Alembic Pharma gets USFDA nod for infection treatment drug
✔️ Alembic Pharma gets final USFDA nod for infection treatment drug
✔️ Alembic Pharma share price up 2% after FDA nod for Azithromycin tablets
✔️ Alembic Pharma posts highest-ever revenues, profit for FY2020
✔️ Alembic Pharma share prices surges 10% on highest-ever profit, revenue in FY20
✔️ Alembic Pharma surges 10% on strong Q4 results; stock zooms 56% in a month
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 25-01-2020 To 22-07-2020
-: Stock News :- APLLTD 25-01-2020 To 22-07-2020

✔️ Alembic Pharma reports better numbers in Q3; here are highlights of analyst call
✔️ Alembic Pharma gets final USFDA nod for infection treatment drug
✔️ Alembic Pharma share price up 2% after FDA nod for Azithromycin tablets
✔️ Alembic Pharma posts highest-ever revenues, profit for FY2020
✔️ Alembic Pharma share prices surges 10% on highest-ever profit, revenue in FY20
✔️ Alembic Pharma surges 10% on strong Q4 results; stock zooms 56% in a month
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 23-01-2020 To 22-07-2020
-: Stock News :- APLLTD 23-01-2020 To 22-07-2020

✔️ Alembic Pharma Consolidated December 2019 Net Sales at Rs 1,209.13 crore, up 18.76% Y-o-Y
✔️ Alembic Pharma gets final USFDA nod for infection treatment drug
✔️ Alembic Pharma share price up 2% after FDA nod for Azithromycin tablets
✔️ Alembic Pharma posts highest-ever revenues, profit for FY2020
✔️ Alembic Pharma share prices surges 10% on highest-ever profit, revenue in FY20
✔️ Alembic Pharma surges 10% on strong Q4 results; stock zooms 56% in a month
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 22-01-2020 To 22-07-2020
-: Stock News :- APLLTD 22-01-2020 To 22-07-2020

✔️ Alembic Pharma Q3 net up 38% to 234 cr
✔️ Alembic Pharma gets final USFDA nod for infection treatment drug
✔️ Alembic Pharma share price up 2% after FDA nod for Azithromycin tablets
✔️ Alembic Pharma posts highest-ever revenues, profit for FY2020
✔️ Alembic Pharma share prices surges 10% on highest-ever profit, revenue in FY20
✔️ Alembic Pharma surges 10% on strong Q4 results; stock zooms 56% in a month
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 21-01-2020 To 22-07-2020
-: Stock News :- APLLTD 21-01-2020 To 22-07-2020

✔️ USFDA inspects Alembic Pharma's Gujarat facility
✔️ Alembic Pharma gets final USFDA nod for infection treatment drug
✔️ Alembic Pharma share price up 2% after FDA nod for Azithromycin tablets
✔️ Alembic Pharma posts highest-ever revenues, profit for FY2020
✔️ Alembic Pharma share prices surges 10% on highest-ever profit, revenue in FY20
✔️ Alembic Pharma surges 10% on strong Q4 results; stock zooms 56% in a month
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 20-01-2020 To 22-07-2020
-: Stock News :- APLLTD 20-01-2020 To 22-07-2020

✔️ Hot Stocks | Alembic Pharma, Siemens can give up to 15% returns in the next 3-4 weeks
✔️ Alembic Pharma gets final USFDA nod for infection treatment drug
✔️ Alembic Pharma share price up 2% after FDA nod for Azithromycin tablets
✔️ Alembic Pharma posts highest-ever revenues, profit for FY2020
✔️ Alembic Pharma share prices surges 10% on highest-ever profit, revenue in FY20
✔️ Alembic Pharma surges 10% on strong Q4 results; stock zooms 56% in a month
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 15-01-2020 To 22-07-2020
-: Stock News :- APLLTD 15-01-2020 To 22-07-2020

✔️ Alembic gets USFDA nod for capsules used to treat spasticity
✔️ Alembic Pharma share price up 2% on USFDA final approval
✔️ Alembic Pharma gets USFDA nod for Tizanidine hydrochloride capsules used to treat spasticity
✔️ Alembic Pharma posts highest-ever revenues, profit for FY2020
✔️ Alembic Pharma share prices surges 10% on highest-ever profit, revenue in FY20
✔️ Alembic Pharma surges 10% on strong Q4 results; stock zooms 56% in a month
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 13-01-2020 To 22-07-2020
-: Stock News :- APLLTD 13-01-2020 To 22-07-2020

✔️ Alembic gets USFDA nod for Vilazodone Hydrochloride tablets used to treat depression
✔️ Alembic Pharma share price up 2% on USFDA final approval
✔️ Alembic Pharma gets USFDA nod for Tizanidine hydrochloride capsules used to treat spasticity
✔️ Alembic Pharma posts highest-ever revenues, profit for FY2020
✔️ Alembic Pharma share prices surges 10% on highest-ever profit, revenue in FY20
✔️ Alembic Pharma surges 10% on strong Q4 results; stock zooms 56% in a month
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 09-01-2020 To 22-07-2020
-: Stock News :- APLLTD 09-01-2020 To 22-07-2020

✔️ Alembic Pharma rises as JV firm completes inspection
✔️ Alembic Pharma rises 3% as JV firm successfully completes USFDA inspection
✔️ Alembic Pharma share price up nearly 3% on successful USFDA inspection
✔️ Alembic Pharma posts highest-ever revenues, profit for FY2020
✔️ Alembic Pharma share prices surges 10% on highest-ever profit, revenue in FY20
✔️ Alembic Pharma surges 10% on strong Q4 results; stock zooms 56% in a month
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 24-12-2019 To 22-07-2020
-: Stock News :- APLLTD 24-12-2019 To 22-07-2020

✔️ USFDA nod may boost Alembic Pharma
✔️ Alembic Pharma rises 3% as JV firm successfully completes USFDA inspection
✔️ Alembic Pharma share price up nearly 3% on successful USFDA inspection
✔️ Alembic Pharma posts highest-ever revenues, profit for FY2020
✔️ Alembic Pharma share prices surges 10% on highest-ever profit, revenue in FY20
✔️ Alembic Pharma surges 10% on strong Q4 results; stock zooms 56% in a month
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 18-12-2019 To 22-07-2020
-: Stock News :- APLLTD 18-12-2019 To 22-07-2020

✔️ Alembic Pharma: EIR certificate bodes well
✔️ Alembic Pharma rises 3% as JV firm successfully completes USFDA inspection
✔️ Alembic Pharma share price up nearly 3% on successful USFDA inspection
✔️ Alembic Pharma posts highest-ever revenues, profit for FY2020
✔️ Alembic Pharma share prices surges 10% on highest-ever profit, revenue in FY20
✔️ Alembic Pharma surges 10% on strong Q4 results; stock zooms 56% in a month
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 02-12-2019 To 22-07-2020
-: Stock News :- APLLTD 02-12-2019 To 22-07-2020

✔️ Company news: Alembic Pharmaceuticals
✔️ Alembic Pharma rises 3% as JV firm successfully completes USFDA inspection
✔️ Alembic Pharma share price up nearly 3% on successful USFDA inspection
✔️ Alembic Pharma posts highest-ever revenues, profit for FY2020
✔️ Alembic Pharma share prices surges 10% on highest-ever profit, revenue in FY20
✔️ Alembic Pharma surges 10% on strong Q4 results; stock zooms 56% in a month
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 22-11-2019 To 22-07-2020
-: Stock News :- APLLTD 22-11-2019 To 22-07-2020

✔️ Company news: Alembic Pharmaceuticals
✔️ Alembic Pharma gets USFDA nod for generic chronic iron overload treatment tablets
✔️ Alembic Pharma share price up nearly 3% on successful USFDA inspection
✔️ Alembic Pharma posts highest-ever revenues, profit for FY2020
✔️ Alembic Pharma share prices surges 10% on highest-ever profit, revenue in FY20
✔️ Alembic Pharma surges 10% on strong Q4 results; stock zooms 56% in a month
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 25-10-2019 To 22-07-2020
-: Stock News :- APLLTD 25-10-2019 To 22-07-2020

✔️ Alembic Pharma Q2 standalone net up 7 per cent
✔️ Alembic Pharma Q2 PAT up 25% at Rs 250 crore
✔️ Alembic Pharma share price up nearly 3% on successful USFDA inspection
✔️ Alembic Pharma posts highest-ever revenues, profit for FY2020
✔️ Alembic Pharma share prices surges 10% on highest-ever profit, revenue in FY20
✔️ Alembic Pharma surges 10% on strong Q4 results; stock zooms 56% in a month
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 24-10-2019 To 22-07-2020
-: Stock News :- APLLTD 24-10-2019 To 22-07-2020

✔️ Company news: Alembic Pharmaceuticals
✔️ Alembic Pharma Q2 PAT up 25% at Rs 250 crore
✔️ Alembic Pharma share price up nearly 3% on successful USFDA inspection
✔️ Alembic Pharma posts highest-ever revenues, profit for FY2020
✔️ Alembic Pharma share prices surges 10% on highest-ever profit, revenue in FY20
✔️ Alembic Pharma surges 10% on strong Q4 results; stock zooms 56% in a month
✔️ Alembic Pharma Q1 profit more than doubles to 301.46 crore
✔️ Alembic Pharma Q1 profit jumps over 2-folds to Rs 301.46 crore
✔️ Alembic Pharma Q1 net profit jumps over two-folds to Rs 301.46 crore
✔️ Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

View Full Story
-: Stock News :- APLLTD 29-07-2022 To 29-07-2022
-: Stock News :- APLLTD 29-07-2022 To 29-07-2022

✔️ Alembic Pharma receive USFDA approval to market drug for skin treatment
✔️ Alembic Pharma receive USFDA approval to market drug for skin treatment

View Full Story

No More Records...